Limited coverage criteria – candesartan (ARB)

Last updated on February 28, 2025

Special Authority requests can now be submitted online. It's simple and quick!

This drug is eligible for automatic approval when patient meets criteria and the request is submitted by eForms.

Generic name	candesartan, including in combination with hydrochlorothiazide
Strength & form	8 mg, 16 mg, 32 mg, 16 mg/12.5 mg, 32 mg/12.5 mg, 32 mg/25 mg tablet

Special Authority criteria	Approval period
Person identified as experiencing intractable cough or angioedema on an angiotensin converting enzyme inhibitor (ACE-I)	Indefinite

Practitioner exemptions

None

Special notes

Individuals requiring a diuretic combination product must satisfy the same criteria
Candesartan 4 mg dose is not a PharmaCare benefit

Special Authority request form

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage criteria – candesartan (ARB)

Generic name

Strength & form

Special Authority criteria

Approval period

Practitioner exemptions

Special notes

Special Authority request form